IBB Holdings Information

IBB is an equity ETF with a total of 267 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 8.67%, Gilead Sciences at 8.05%, Amgen at 7.83%, Regeneron Pharmaceuticals at 6.89%, and Alnylam Pharmaceuticals at 4.51%.

Total Holdings

267

Top 10 Percentage

49.02%

Asset Class

Equity

ETF Category

Health

Assets

8.68B

PE Ratio

23.92

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	8.67%	1,612,549
2	GILD	Gilead Sciences, Inc.	8.05%	5,556,399
3	AMGN	Amgen Inc.	7.83%	2,024,017
4	REGN	Regeneron Pharmaceuticals, Inc.	6.89%	755,726
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.51%	969,109
6	INSM	Insmed Incorporated	3.24%	1,570,660
7	ARGX	argenx SE	2.97%	302,276
8	NTRA	Natera, Inc.	2.66%	980,896
9	BIIB	Biogen Inc.	2.25%	1,093,755
10	ONC	BeOne Medicines AG	1.96%	539,999
11	UTHR	United Therapeutics Corporation	1.83%	310,209
12	ILMN	Illumina, Inc.	1.74%	1,109,172
13	INCY	Incyte Corporation	1.69%	1,450,288
14	GMAB	Genmab A/S	1.43%	3,672,214
15	NBIX	Neurocrine Biosciences, Inc.	1.22%	725,006
16	RVMD	Revolution Medicines, Inc.	1.16%	1,234,540
17	MEDP	Medpace Holdings, Inc.	1.11%	168,771
18	IONS	Ionis Pharmaceuticals, Inc.	1.10%	1,186,330
19	BBIO	BridgeBio Pharma, Inc.	1.08%	1,228,874
20	MDGL	Madrigal Pharmaceuticals, Inc.	1.07%	154,051
21	EXEL	Exelixis, Inc.	1.04%	1,939,203
22	BMRN	BioMarin Pharmaceutical Inc.	0.98%	1,413,762
23	MRNA	Moderna, Inc.	0.94%	2,588,493
24	RNA	Avidity Biosciences, Inc.	0.86%	1,031,414
25	CRL	Charles River Laboratories International, Inc.	0.86%	363,218

Showing 25 of 267 holdings

Subscribe to see the full list

Activate Now

As of Dec 26, 2025